|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2004-11-16
|
|
pubmed:abstractText |
To report 2 cases of acute renal failure (ARF) following administration of sucrose-stabilized intravenous immune globulin (IVIG), one of which did not recur following subsequent doses of d-sorbitol-stabilized formulation, and review the relevant literature.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1060-0280
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2059-67
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15536143-Acute Kidney Injury,
pubmed-meshheading:15536143-Adult,
pubmed-meshheading:15536143-Aged,
pubmed-meshheading:15536143-Aged, 80 and over,
pubmed-meshheading:15536143-Drug Stability,
pubmed-meshheading:15536143-Humans,
pubmed-meshheading:15536143-Immunoglobulins, Intravenous,
pubmed-meshheading:15536143-Male,
pubmed-meshheading:15536143-Pharmaceutical Solutions,
pubmed-meshheading:15536143-Renal Dialysis,
pubmed-meshheading:15536143-Sorbitol,
pubmed-meshheading:15536143-Sucrose,
pubmed-meshheading:15536143-Time Factors
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.
|
|
pubmed:affiliation |
Clinical Specialist-Transplant Therapeutics and Research, Abbott Northwestern Hospital, Minneapolis, MN, USA. chapm004@umn.edu
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
